Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
Nextech3D.ai Announces First New Customer Win For its AI Powered Photography Studio (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
ProMIS Neurosciences Inc
PMN
Healthcare
Biotechnology
ProMIS Neurosciences Inc. is a clinical-stage biotechnology company. It is focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer’s disease (AD), amyotrophic lateral sclerosis (ALS) and multiple system atrophy (MSA). Its proprietary target discovery engine applies a thermodynamic, computational...
discovery platform-ProMIS and Collective Coordinates-to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins. Using this approach, the Company is developing novel antibody therapeutics for AD, ALS and MSA. Its product candidates are PMN310, PMN267, and PMN442. The PMN310 is a monoclonal antibody designed to treat AD by selectively targeting toxic, misfolded oligomers of amyloid-beta. PMN267 product candidate targeting ALS. PMN442 is a drug candidate being developed for MSA designed to selectively target and protect against pathogenic a-syn species.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (NDAQ:PMN)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(106)
•••
G1945V
X
View Profile
View Bullboard History
Comment by
G1945V
on Sep 12, 2024 2:30pm
RE:New Press Release - ProMIS Neurosciences to Showcase PMN310's Ability to Target Toxic Oligomers and Distinguish from Other Amyloid-Beta Oligomers in Preclinical Studies at the 4th International Conference on Cognitive & Behavioral Neurosciences
Has anyone found the slide presentation referred to in the press release? "The slide presentation is available on the Posters and Publications page of the Company’s website at www
...more
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Sep 12, 2024 7:00am
New Press Release - ProMIS Neurosciences to Showcase PMN310's Ability to Target Toxic Oligomers and Distinguish from Other Amyloid-Beta Oligomers in Preclinical Studies at the 4th International Conference on Cognitive & Behavioral Neurosciences
CAMBRIDGE, Massachusetts and TORONTO, Ontario, Sept. 12, 2024 (GLOBE NEWSWIRE) -- ProMIS Neurosciences Inc. (Nasdaq: PMN), a biotechnology company focused on the generation and development of antibody therapeutics targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer...
read article.
(12)
•••
Hafness
X
View Profile
View Bullboard History
Comment by
Hafness
on Sep 10, 2024 11:10pm
RE:October 23 BS meeting
Can someone break this down. Is this for funding for pmn310 or more dilution. Seems they go hand and hand?
(20)
•••
FarmerBetsy
X
View Profile
View Bullboard History
Comment by
FarmerBetsy
on Sep 10, 2024 8:55pm
RE:RE:RE:Warma
C'mon bball you know these guys are scammers just a few powerful shareholders controlling this. Look at the 20 year chart the stock at the lowest point in 20 years then the 3 volume explosions in
...more
(198)
•••
goldtech
X
View Profile
View Bullboard History
Post by
goldtech
on Sep 10, 2024 8:44pm
October 23 BS meeting
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to
...more
(198)
•••
goldtech
X
View Profile
View Bullboard History
Post by
goldtech
on Sep 10, 2024 4:18pm
Manipulative trading
If you ever experienced a more contrivedanipulative traded stock on the NASDAQ, Promis is the one.
(61)
•••
bball67
X
View Profile
View Bullboard History
Comment by
bball67
on Sep 10, 2024 2:05pm
RE:RE:Warma
Here you go again. Not enough employees. Look at Worldwide Clinical Trials.
(20)
•••
FarmerBetsy
X
View Profile
View Bullboard History
Comment by
FarmerBetsy
on Sep 10, 2024 9:16am
RE:Warma
The brillant six employees. Acumenpharma had about 40 staff in their phase1 with 65 enrolled. Promis is talking about enrolling 100 for phase 1b . They better be just not brillant but the super 6
...more
(106)
•••
G1945V
X
View Profile
View Bullboard History
Comment by
G1945V
on Sep 10, 2024 5:41am
RE:RE:RE:RE:presentation available tomorrow at 0700 eastern
"Actually, the answer is at 15:30 into the presentation. There is a whole slide showing all the cohorts and confirming they've all been analyzed, with no adverse events and good
...more
(93)
•••
Gbathat
X
View Profile
View Bullboard History
Comment by
Gbathat
on Sep 09, 2024 10:15pm
RE:RE:RE:presentation available tomorrow at 0700 eastern
Actually, the answer is at 15:30 into the presentation. There is a whole slide showing all the cohorts and confirming they've all been analyzed, with no adverse events and good tolerability.
...more
(93)
•••
Gbathat
X
View Profile
View Bullboard History
Post by
Gbathat
on Sep 09, 2024 10:09pm
Warma
Warma is a great CEO... Good communicator, believes in what ProMIS is doing, understands it, and gives credit to the brilliant team behind it. End of Phase 1b will be 'transforming time for the
...more
(20)
•••
FarmerBetsy
X
View Profile
View Bullboard History
Comment by
FarmerBetsy
on Sep 09, 2024 9:58pm
RE:RE:presentation available tomorrow at 0700 eastern
Easy answer it is all about delay..They could have easily done a small phase 1 in alzheimer patients by adding people to the organization and getting it off the ground last year. They didn't
...more
(106)
•••
G1945V
X
View Profile
View Bullboard History
Comment by
G1945V
on Sep 09, 2024 9:24am
RE:presentation available tomorrow at 0700 eastern
No update on Cohort 5...Why Not? G1945V
(12)
•••
Hafness
X
View Profile
View Bullboard History
Comment by
Hafness
on Sep 09, 2024 9:21am
RE:presentation available tomorrow at 0700 eastern
I'm checking out the website now to see if it's up
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Alphamin Announces Record Fy2024 & Q4 2024 Tin Production Fy2025 Production Guidance Exploration Success
BioVaxys Developing DPX to be the Carrier of Choice for mRNA Vaccines, a market projected to grow to USD$48,000,000,000 by 2030*
Eminent's First Drill Hole Hits Significant Gold-Arsenic in Getchell Trend Analogue and Second Hole Drilling Commences
U.S. DOD Logistics Agency Highlights V.GPH Project to Develop Eco-Friendly Graphite-Based Fire-Fighting Material
Have you held units of a TD mutual fund, other than through a discount broker? Learn more.